To evaluate the effect of vitamin B 6 status on infant growth, we studied longitudinally anthropometry and the erythrocyte parameters that reflect long-term vitamin B 6 status [erythrocyte pyridoxal 5 '-p hosphate concentration (EPLP), erythrocyte aspartate transaminase basal activity (EAST0)' and its activation coefficient (aEAST)] in 44 infants. The infants were exclusively breast-fed for 6 mo, given additional solids according a uniform schedule from 6-9 mo, and formula after 9 mo, if needed. In seven of these infants, a low vitamin B 6 status (EPLP < 10th, and EAST o > 10th or aEAST > 90th percentile for these values in reference infants) was observed between 4 and 6 mo of age. These seven infants showed slower length velocity (0.30 ± 0.05 versus 0040 ± 0.02 mm/d, p s 0.02) and deeper fall in lengthfor-age (-0.69 ± 0.20 versus -0.25 ± 0.07 SD score, p S 0.03) from 6 to 9 mo of age than the similarly fed infants with higher vitamin B 6 status. Preceding vitamin B 6 status remained a significant explanatory factor for length velocity and change in length-for-age in addition to preceding and concomitant weight velocity, when sex, birth size, preceding length gain, and midparent height were taken into account. Change in weight-for-age alone explained 16% and 18% and, together with vitamin B 6 
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In animals, vitamin B 6 deficiency leads to slowing of weight gain (13, 14) , which can be restored by pyridoxine administration (14, 15) . The higher the protein intake, the earlier and the greater the growth retardation (15, 16) . In human infants, status, 23 and 27% of the variation in length velocity and in change in length-for-age, respectively. Thus, in healthy breastfed infants, according to our results, low vitamin B 6 status is 'associated with reversibly reduced gain in length. iPediatr Res 38: [740] [741] [742] [743] [744] [745] [746] 1995) Abbreviations PPLP, plasma pyridoxal 5 '-phosph ate concentration EPLP, erythrocyte pyridoxal 5' -phosphate concentration EAST, erythrocyte aspartate aminotransferase (EC 2.6.1.1) EAST0' EAST basal activity EAST +' EAST stimulated activity aEAST , EAST activation coefficient = EAST +:EAST o PN·HCl, pyridoxine hydrochloride adeB 6 infants, infants with adequate vitamin B 6 status during breast feeding lowB 6 infants, infants with low vitamin B 6 status during breast feeding SDS, SD score some investigat ors have also found an aSSOCIatIOn between vitamin B 6 status and growth (17, 18) . Snyderman et al observed failure to gain weight in infants on diet devoid of vitamin B 6 (17) . In a study by Kang-Yoon et al the breast-fed infants with considerable maternal and/or infant vitamin B 6 supple mentation showed greater increase in weight and length Z scores than the infants whose mothers were less supplemented (18) . In addition, infant vitamin B 6 intake and plasma pyridoxal 5 ' -phosphate concentration predicted weig ht gain during the first month of life (18) .
Er ythrocyte vitamin B 6 param eters, including EPLP, EAST o ' and its activation coefficient aEA ST, reflect long-term vitamin status. We have reported strikingly higher vitamin B 6 status in formula-fed than in exclusively breast-fed infants during the first 6 mo of life (19) . Of formul a-fed infants, 50-96% had values for the long-t erm vitamin B 6 parameters above the 95th percentile for these values in breast-fed infants (19) . In addition, we have found that the infant's risk of low vitamin B 6 status increases after 6 mo of exclusive breast feedin g (Heiskanen K, Siimes MA, Perheentupa J, Salme npera L, unpublished data).
To foll ow possible associations between vitamin B 6 status and growth in breast-fed infants fed according to the current WHO feeding recommendations, we used anthropometry and erythrocyte parameters which reflect long-term vitamin B 6 status.
METHODS

Subjects.
We follow ed the growth and nutritional status of 198 infants from birth to 12 mo of age. They wer e healthy full-term (37-42 gestation wk) singletons with uncomplicated delive ry after normal pregnancy, birth weights appropriate for gestational age , and Apga r sco res :2:8 at 1 min . Of these infants, the 44 includ ed in this study (20 boys and 24 girls) were exclusively breast-fed for 6 mo, given additional solids according a uniform schedule from 6-9 mo, and formul a after 9 mo, if needed. At 12 mo, all the infants were still partly breast-fed; 20 of them were breast-fed and given add itional solids, 24 of them we re breast-fed and given additional formula and solid s. Measurements. Birth length and we ight were measured by the nurs es of the maternity unit. All the infants were examined and measur ed at 1, 2, 3, 4, 5, 6, 7.5, 9, and 12 mo by one of the authors (L.S.). Naked weight was measured to the nearest 5 g on an infant scale. Length to the nearest millimeter with the child lying on a board with fixed headpi ece and a mova ble footpi ece.
Th e most recent Finn ish standards were used for determining length-for-age in SDS and we ight-for-age in percent of medi an weight for age and sex. Th e growth velocitie s for 2-3-mo age intervals were calculated by dividing the increments (mm or g) by the actual time interval (d). The midp arent height (SDS) was calcul ated.
Blood samples. Venous blood samples were taken at 2,4,6, 9, and 12 mo of age. For the determinations of vitamin B 6 parameters, samples of 4 mL were collec ted into tubes lined with sodium heparin (Bec ton Dickinson Vacut ainer, Plymouth , UK) and centrifuged immediately at 770 X g for 5 min at room temp erature ; the cells were transferred to a sterile brown glass septum ampule containing 0.75 mL of amino acid-citric aciddextrose solution as stabilizer. The sampl es, kept at 4-6°C, were transported daily by air to the Department of Clinical Nutrition, Roche Holding Ltd ., Basl e, Switzerland, for determination s of EPLP and the EAST stimulation test.
Protein status. Total serum protein was determined by the biur et reac tion, and prealbumin and transferrin by imrnunoturbidim etry .
Assay of EPLP.
The EPLP assay was a modified version (20) of the method of Reinken (21) , based on decarboxylation of 14C-L-tyrosine by reco nstituted tyrosine decarb oxylase after trichloroacetic acid prec ipitat ion of protein from the erythrocyte suspension. The results are expresse d as nmol/L of pure ery throcy tes at a calculated hem atocrit of 100 %. In vitamin B 6 deficiency EPLP , the active metabolite of vitamin B 6 , is decreased .
EAST stimulation test. Transam ination of aspartic acid to 2-oxo glutarate was monitored with (EAST +) and without (EAST0) excess PLP , according to a modification (20) of the meth od of Stanulovic et al. (22) . Results are given as J.Lkat/L eryth rocytes, wher e J.Lkat represents the amount of substrate (umol) transform ed per sec ond. The activa tion coe fficient aEAST was calcul ated. In vitamin B 6 deficiency, EAST o ' in which PLP acts as a coe nzyme, is decreased, and a EAST, which reflects desatur ation of EAST with its coenz yme, is increased.
Ref erence values.
As reference popul ation we used infants exclusive ly breast-fed up to 6 mo of age by mothers wit h an adequ ate vitamin B 6 status, given solids in additi on from 6 mo of age, and weaned to cow milk via formula after 9 mo of age (23) . We used the 10th percen tile of the EPLP and EAST o values as cutoff points for low values, and the 90t h percentile of the aEAST values as cutoff point for high va lues (23) . Coincidence of at least two values beyond the cutoffs (Table 1) of the three was taken to indicate low vitamin B 6 status (23) . As a result, we detected of the reference infants those with their vitamin B 6 status in the lowest 5-9% at eac h age (2, 4, 6, 9, and 12 mo) (23).
Infants with low vitamin B6 status in the present study.
A low vitamin B 6 statu s was observed between 4 and 6 mo of age in seve n (IowB 6 ; in the lowest decile for vitamin B 6 status, determined with EPLP and EAST stimulation test, in breastfed reference infants) of the 44 infants; in three of them (7%) at 4 mo and in four (9%) at 6 rno of exclusive breas t feedin g (Tab le 1). Vitam in B 6 status of these infants was adequate at 9 and 12 mo. Th e gro up characteristics for the lowB 6 infants and for those who had adequate vitamin B 6 status (ade B 6 ; above the lowest decile for vitamin B 6 status, determin ed with EPLP and EAST stimulation test, in breast-fed reference infants) are given in Table 2 . Mean length and mean length-for-age at each age were similar for the lowfs; and adels, infants.
Statistical analysis. The data were analyzed with Statview 512+ from MacIntosh (Brainpower, Calabasas, CA). We used analysis of varia nce for repea ted measurements, the nonpa rametric Friedman two-wa y analysis of variance for repeated measur ements for longitudinal evaluation of grow th parameters, and t test and the Mann-Whitney U test to identify group differences in grow th. Pearson correlation coe fficients were calcul ated from regression anal yses of these growt h and vitamin B 6 status par ameters to analyze their relations. Multipleline ar-regression analyses were performed to examine relationship between vitamin B 6 status (included as a category factor = low or adequate during exclusive breas t feed ing) and sub- Gain in weight and length in infants with adequate and low vitamin B6 status. From 1 to 12 mo, mean weight and mean weight-for-age did not differ in the lowB 6 and the adels, infants, even though the mean absolute and relative birth weights were higher in the Jowls, than in the adeB 6 infants (mean ± SEM 3741 ± 78 g versus 3438 ± 39 g, p ::s 0.003, and 6.3 ± 2.3% versus -1.5 ± 1.1%, p ::s 0.008, respectively, Table 2 ). By 9 mo of age, mean weight-for-age had fallen more in the lowB 6 than in the adels, infants (p ::s 0.02; Fig. 1) . The difference between their weight velocities when determined for 2-3-mo age intervals were not statistically significant (Table 3) .
From birth to 6 mo, mean length increments (mm), mean length velocity (Table 3) , and changes in length-for-age in the lowls, infants did not differ from those in the adels; infants.
Between 6 and 9 mo the lowfl, infants grew more slowly than the adeb, infants. p ::s 0.007), and in mean length velocity from birth to 6 mo of age (p ::s 0.005), but the difference was not significant when length velocity was compared at 2-3-mo age intervals. Thus, the data for boys and girls were generally combined for analyses. Mean weight-and length-for-age increased from birth to 2 mo, and then decreased gradually until 9 mo ( -r-,-......--,-......-..,........,--,-....,--,---.-. 6 ) and with low (lowB 6 ) vitamin B 6 status in the lowls, than in the adeB 6 infants (-0.69 ± 0.20 versus -0.25 ± 0.07 SDS, p :5 0.03) between 6 and 9 mo (Fig. 2) . A decrease in SDS of > 1.0 SD from birth occurred by 6 rna in 30% and by 9 rna in 71% of the lowls, infants versus 13 and 30%, respectively, of the adeB 6 infants. In the lowB 6 infants, mean length velocity was higher between 9 and 12 mo than between 6 and 9 rna (p :5 0.05), but in the adeB, infants it was stable between 6 and 12 mo. In all the lowB 6 infants length-for-age increased from 9 to 12 mo. In two of them, length velocity was 3-4-fold higher between 9 and 12 rna than between 6 and 9 rna, and length-far-age increased by 1.4 and 1.5 SD units between 9 and 12 rna of age. Individual data on longitudinal growth of the lowfs, infants is shown in Table 1 .
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Tab le 3. Mean (±SEM) length and weight velocity determined for 2-3-mo age intervals in infants with adequate (adeB
Longitudinal growth in infants with low and adequate vitamin B6 status. Length velocity and change in length-forage between 6 and 9 rna correlated positively with preceding and concomitant weight velocity (4-9 rna), change in weightfor-age (4-9 mo; r = 0.41-0.45, p :5 0.003-0.05), and preceding vitamin B 6 status (determined at each age concomitantly with EPLP and EAST stimulation test, and used as a category factor; adequate or low at 4-6 rna; Spearman r = 0.28-0.31, p :5 0.05-0.07). In addition, change in length-forage (6-9 rna) correlated inversely with absolute and relative Of the analyzed factors, length gain correlated best with weight gain, and better with change in weight-far-age than with weight velocity. Further, the change in weight-for-age during the age period 4-9 rna had a higher correlation with longitudinal growth between 6 and 9 mo than changes in weight-for-age during any other age periods. Therefore, change in weight-for-age from 4 to 9 mo (partly reflecting total energy and protein intake) was included in the multiple regression analyses for length velocity (6-9 mo) and for change in length-far -age (6-9 mo), as well as preceding vitamin B 6 status (adequate or low at 4-6 rna) as explanatory factors. As possible confounding factors, sex, relative birth weight (observed difference between the adeB 6 and the Iowfl, infants), and difference between length-for-age at 6 mo and midparent height (reflecting preceding longitudinal growth and possible tendency to grow toward midparent height) were also included in the analyses. The strongest explanatory factor for length velocity and for change in length-far-age between 6 and 9 mo was change in weight-for-age (4-9 mo). The association between vitamin B 6 status (4-6 rna) and length velocity or length-for-age (6-9 mo) could not be explained by variation in the other variables included in the analyses. In the forward stepwise multiple regression analyses, change in weight-forage explained 16 and 18%, and its combination with preceding vitamin B 6 status 23 and 27%, of the variation in length velocity and in change in length-for-age, respectively (Tables 4  and 5) .
Vitam in B6 statu s and longitudinal growth in pairs matched for birth weight. To exclude the possibility that our results were affected by the difference in birth weight between the lowfl, and the adefs, infants, we selected for each of the seven lowls, infants pairs matched for sex and birth weight from among the adels, infants. The lowls, infants had a lower length velocity (0.30 ± 0.05 versus 0.41 ± 0.16 mrn/d; onetailed t test, p :5 0.06) and a deeper fall in length-far-ag e from 6 to 9 rna of age (-0.69 ± 0.20 versus -0.25 ± 0.16 SDS; one-tailed t test, p :5 0.06) than their matched adeB 6 infant pairs. Table 4 . Multiple linear regression analysis fo r different variables explaining length velocity between 6 and 9 mo of age Sex Relative birth weig ht (% of median) Vitamin B 6 status at 4-6 mo (low/adequate) Difference between midpare ntal height and length-for-age at 6 mo Change in weight-for-age from 4 to 9 mo
Forward stepwise multipl e regression analysis (inclusion criteria : F = 4.0, P :5 0.05)
Step 1 (R = 0.42, adj usted R 2 = 0.16) Change in weight -far-age from 4 to 9 rna
Step 2 (R = 0.52, adjusted R 2 = 0.23, P :5 0.002) Change in weight-for-age from 4 to 9 rna Vitamin B 6 status at 4-6 mo (low/ad equ ate) 6 and the adefs, infants did not differ in plasma protein, prealbumin, or transferrin concentrations at 4 mo (60 ± 2 versus 60 ± 1 g/L, 182 ± 19 versus, 175 ± 6 mg/L, and 2.5 ± 0.2 versus 2.5 ± 0.1 mg/L, respectively), at 6 mo (63 ± 1 versus 62 ± 1 g/L, 173 ± 20 versus 167 ± 4 mg/L, and 2.6 ± 0.2 versus 2.6 ± 0.1 mg/L, respectively), or at 9 mo (63 ± 1 versus 62 ± 1 gIL, 201 ± 2 versus 197 ± 10 mg/L, and 3.0 ± 0.2 versus 2.8 ± 0.1 mg/L, respectively).
DISCUSSION
General growth pattern. For this study, we selected a group of infants standardized for type of feed to minimize the intragroup variation in the intake of nutrients. Their feeding pattern was in accord with the current recommendations by WHO and, as a group, these infants grew as expected for breast-fed infants (3, 4) . During exclusive breast feeding their weight-for-age percentiles fell, and the fall continued well after the introduction of solid foods. Maximal length-for-age was attained by 2 mo, as in the DARLING study infants, and the SDS then fell for longer and deeper, possibly because solid foods were introduced later than in the DARLING study. Weight velocity and length velocity calculated for 2-3-mo age intervals were similar to those observed in breast-fed infants (5, 9) .
Slower growth rate in infants with low vitamin B6 status. A new observation is that, in breast-fed infants, a low vitamin B 6 status is associated with subsequently slowed length velocity and a deeper fall in length-for-age. This is in accord with the earlier described correlation between vitamin B 6 intake and length gain in breast-fed neonates (18) .
Weight gain has been observed to correlate with vitamin B 6 status both in animal experiments and in human neonates (14, 18) . In our study, the breast-fed infants with a low vitamin B 6 status had a poorer weight gain than those with an adequate status. This difference became evident even during the first 4 mo and in all probability was mostly due to the difference in mean birth weight between the groups. On the other hand, there was a constant positive correlation between parameters reflecting long-term vitamin B 6 status and preceding weight gain. The association reflects most probably the amount and quality of breast milk (24).
Because there are no studies about metabolic or hormonal effects of vitamin B 6 deficiency in human infants, we can only speculate on the mechanisms underlying the association between vitamin B 6 and infant growth. Vitamin B 6 acts as a coenzyme in protein, carbohydrate, and fat metabolism. The higher the protein intake, the higher the requirement for vitamin B 6 or the earlier the signs of the vitamin deficiency. Thus, low vitamin B 6 status could lead in ineffective utilization of dietary proteins for growth. In animal studies, vitamin B 6 deficiency has also been shown to produce alterations in action of hormones, including insulin, and thyroid hormone (25) .
The possible effects of low vitamin B 6 status on utilization of dietary proteins and on the hormonal balance could partly explain poorer growth of our lowfl, infants, and be involved in causing the difference in growth pattern between breast-and formula-fed infants and, especially, the growth faltering of some breast-fed infants (26) .
Reversible threshold phenomenon not resulting in stunting. Vitamin B 6 does not seem to be a growth factor. The association between longitudinal growth and individual vitamin B 6 parameters appeared only during the period in which low vitamin B 6 status was observed, and reduced length velocity was later observed in those infants in whom at least two of the three vitamin B 6 parameters were beyond the used cutoffs. This suggests that longitudinal growth is affected by vitamin B 6 status only beneath a certain threshold level and after a delay. In animal and human studies, vitamin B 6 deficiency has been shown to result in decreased weight gain only after a delay (14, 17) which is the shorter, the higher the dietary protein intake (14) . Our infants with a low vitamin B 6 status between 4 and 6 mo also had a low protein intake due to exclusive breast feeding. When additional solid foods were introduced and protein intake thus gradually increased, their longitudinal growth slowed down and length-for-age decreased further.
The slowing of growth was reversible and did not result in shorter stature at the end of the first year. After 6 mo of age, the infants received increasing amounts of solids and were weaned via formula to cow milk, presumably resulting in a gradually increasing intake of total energy, protein (8) , and vitamin B 6 . Vitamin B 6 status improved by 9 mo, and thereafter length velocity recovered and length -for-age return ed to earlier levels.
Confounding factors influencing growth.
A fact that complicates evaluation of our findings is the higher mean birth weight of the lowls, infant s compared with the adefl , infants. Extenuating facts are that the negati ve correlation between birth weight and growth was evident only during the first 2 mo and that from 2 mo of age the group s did not differ in absolute or relative weight. Nor did birth weight correlate with length velocity at any age. Furthermore , in multipl e regression analysis, the negative correlation between birth weight and changes in length-for-age between 6 and 9 mo was explained by variation in the other explanatory var iables. As expected, the preceding and concomitant change in weight-for-age strongly explained both length velocity and change in length-for-age. In addition , preceding vitamin B 6 status remained a significant explan atory factor for longitudinal growth from 6 to 9 rna of age eve n though factors earlier report ed to influence grow th were taken into account, including sex, size at birth , preceding and concomit ant weight gain (partly reflecting total energy and protein intake), and inherited growth pattern . Furthermore, similar plasma prealbumin and transferrin levels of the groups strengthen the view that the growth difference was not due to significantly different protein or energy intake.
To conclude: in healthy breast-fed infants, a low vitamin B 6 status seems to be associated with reversible reducti on of length velocity accompanied by decrease in length-for-age. This associa tion and the underlying mechanisms need further investigation.
